PTPN11 and non-small cell lung carcinoma: Besides, SHP2 is related to some functions of PD-1/PD-L1, thus playing a role in the regulation of immune system.260–264 In addition, SHP2 overexpression or activation can mediate drug resistance in various cancers, including leukemia, non-small cell carcinoma, and breast cancer.